The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.

MLA

Andrews, Jason R., et al. “The Cost-Effectiveness of Routine Tuberculosis Screening with Xpert MTB/RIF Prior to Initiation of Antiretroviral Therapy: A Model-Based Analysis.” AIDS (London, England), vol. 26, no. 8, May 2012, pp. 987–95. EBSCOhost, https://doi.org/10.1097/QAD.0b013e3283522d47.

APA

Andrews, J. R., Lawn, S. D., Rusu, C., Wood, R., Noubary, F., Bender, M. A., Horsburgh, C. R., Losina, E., Freedberg, K. A., & Walensky, R. P. (2012). The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS (London, England), 26(8), 987–995. https://doi.org/10.1097/QAD.0b013e3283522d47

Chicago

Andrews, Jason R, Stephen D Lawn, Corina Rusu, Robin Wood, Farzad Noubary, Melissa A Bender, C Robert Horsburgh, Elena Losina, Kenneth A Freedberg, and Rochelle P Walensky. 2012. “The Cost-Effectiveness of Routine Tuberculosis Screening with Xpert MTB/RIF Prior to Initiation of Antiretroviral Therapy: A Model-Based Analysis.” AIDS (London, England) 26 (8): 987–95. doi:10.1097/QAD.0b013e3283522d47.